nemonapride nemonapride nemonapride (エミレース, emilace (jp)) is an atypical antipsychotic approved in japan for the treatment of schizophrenia. it was launched by yamanouchi in may 1991. nemonapride acts as a d2 and d3 receptor antagonist, and is also a potent 5-ht1a receptor agonist. it has affinity for sigma receptors. nemonaprideclinical datatrade namesemilace (jp)ahfs/drugs.cominternational drug namesroutes ofadministrationoralatc codenonelegal statuslegal status rx-only (jp) identifiers iupac name n-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide cas number75272-39-8pubchem cid4452iuphar/bps983chemspider4297uniiq88t5p3444keggd01468 ychebichebi:64217chemblchembl20734pdb ligandaqd (pdbe, rcsb pdb)chemical and physical dataformulac21h26cln3o2molar mass387.91 g·mol−13d model (jsmol)interactive image smiles cc1c(ccn1cc2=cc=cc=c2)nc(=o)c3=cc(=c(c=c3oc)nc)cl inchi inchi=1s/c21h26cln3o2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23h,9-10,13h2,1-3h3,(h,24,26)key:krvojoclbaaksj-uhfffaoysa-n (verify)